[1]
E. Kristin, D. Endarti, R. P. Febrinasari, D. A. A. Nugrahaningsih, and W. R. Pratiwi, “Budget Impact Analysis of Sacubitril Valsartan in the Treatment of Heart Failure and Reduced Ejection Fraction (HFrEF) in Indonesia”, Indonesian J Pharm, vol. 33, no. 1, pp. 83-92, Feb. 2022.